Jonsson Comprehensive Cancer Center: Central Nervous System Neoplasms trials
The registry lists 16 Central Nervous System Neoplasms studies with Jonsson Comprehensive Cancer Center as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 8Phase 2 8No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT01013285Phase 2Results posted
- Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT00998010Phase 2Results posted
- Rosiglitazone in Treating Patients With Pituitary TumorsTerminatedNCT00616642Phase 2Results posted
- Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00612001Phase 1
- Temozolomide in Treating Patients With Invasive Pituitary TumorsWithdrawnNCT00601289Phase 2
- Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant GliomaCompletedNCT00509431Phase 1
- Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant GliomaCompletedNCT00107185Phase 1
- Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant GliomaCompletedNCT00087061Phase 1/2
- Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00068510Phase 1
- Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain CancerCompletedNCT00052286Not applicable
- Sirolimus in Treating Patients With Glioblastoma MultiformeCompletedNCT00047073Phase 1/2
- Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade AstrocytomaStatus unknownNCT00005084Phase 2
- Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain TumorsWithdrawnNCT00005083Phase 2
- Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed GliomaCompletedNCT00005082Not applicable
- Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade GliomasCompletedNCT00003410Phase 1
- Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00003409Phase 1